Chromosomal rearrangements and microRNAs: A new cancer link with clinical implications

Journal of Clinical Investigation

Volumn 117, Issue 8, 2007, Pages 2059-2066

  Calin, George A ^a,c   Croce, Carlo M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

CANCER GENETICS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; GENE EXPRESSION; GENE LOCUS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; PROGNOSIS; QUANTITATIVE TRAIT LOCI;

EID: 34547702505     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32577     Document Type: Review

References (101)

1. Jemal, A., et al. 2007. Cancer statistics, 2007. CA Cancer J. Clin. 57:43-66.
2. Bishop, J.M. 1991. Molecular themes in oncogenesis. Cell. 64:235-248.
3. Hunter, T. 1991. Cooperation between oncogenes. Cell. 64:249-270.
4. Weinberg, R.A. 1991. Tumor suppressor genes. Science. 254:1138-1146.
5. Calin, G.A., and Croce, C.M. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 6:857-866.
6. Esquela-Kerscher, A., and Slack, F.J. 2006. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer. 6:259-269.
7. Calin, G.A., et al. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101:2999-3004.
8. Calin, G.A., and Croce, C.M. 2006. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 25:6202-6210.
9. Storz, G., Altuvia, S., and Wassarman, K.M. 2005. An abundance of RNA regulators. Annu. Rev. Biochem. 74:199-217.
10. Lee, R.C., Feinbaum, R.L., and Ambros, V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843-854.
11. Wightman, B., Ha, I., and Ruvkun, G. 1993. Post-transcriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 75:855-862.
12. Ambros, V. 2003. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 113:673-676.
13. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297.
14. Griffiths-Jones, S., Grocock, R.J., van Dongen, S., Bateman, A., and Enright, A.J. 2006. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34:D140-D144.
15. Chen, C.Z., Li, L., Lodish, H.F., and Bartel, D.P. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science. 303:83-86.
16. Harfe, B.D. 2005. MicroRNAs in vertebrate development. Curr. Opin. Genet. Dev. 15:410-415.
17. Lim, L.P., et al. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769-773.
18. Mitelman, F., Johansson, B., and Mertens, F. 2007. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer. 7:233-245.
19. Nowell, P.C., and Hungerford, D.A. 1960. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst. 25:85-109.
20. Rowley, J.D. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:290-293.
21. Croce, C.M., and Nowell, P.C. 1985. Molecular basis of human B cell neoplasia. Blood. 65:1-7.
22. Croce, C.M. 1987. Role of chromosome translocations in human neoplasia. Cell. 49:155-156.
23. Russo, G., et al. 1988. Molecular analysis of a t(7;14)(q35;q32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia. Cell. 53:137-144.
24. Rabbits, T.H. 2001. Chromosomal translocation master genes, mouse models and experimental therapeutics. Oncogene. 20:5763-5777.
25. Rowley, J.D. 2001. Chromosome translocations: dangerous liaisons revisited. Nat. Rev. Cancer. 1:245-250.
26. Perrotti, D., and Calabretta, B. 2004. Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene. 23:3222-3229.
27. Kantarjian, H.M., Talpaz, M., Giles, F., O'Brien, S., and Cortes, J. 2006. New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance. Ann. Intern. Med. 145:913-923.
28. Venturini, L., et al. 2007. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 109:4399-4405.
29. Calin, G.A., and Croce, C.M. 2006. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 66:7390-7394.
30. Arlt, M.F., Casper, A.M., and Glover, T.W. 2003. Common fragile sites. Cytogenet. Genome Res. 100:92-100.
31. Richards, R.I. 2001. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet. 17:339-345.
32. Calin, G.A., et al. 2002. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99:15524-15529.
33. McManus, M.T. 2003. MicroRNAs and cancer. Semin. Cancer Biol.13:253-258.
34. Berezikov, E., and Plasterk, R.H. 2005. Camels and zebrafish, viruses and cancer: a microRNA update. Hum. Mol. Genet. 14:R183-R190.
35. Gregory, R.I., and Shiekhattar, R. 2005. MicroRNA biogenesis and cancer. Cancer Res. 65:3509-3512.
36. Croce, C.M., and Calin, G.A. 2005. miRNAs, cancer, and stem cell division. Cell. 122:6-7.
37. Caldas, C., and Brenton, J.D. 2005. Sizing up miRNAs as cancer genes. Nat. Med. 11:712-714.
38. Chen, C.Z. 2005. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 353:1768-1771.
39. Calin, G.A., Garzon, R., Cimmino, A., Fabbri, M., and Croce, C.M. 2005. MicroRNAs and leukemias: how strong is the connection? Leuk. Res. 30:653-655.
40. Hwang, H.W., and Mendell, J.T. 2006. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer. 94:776-780.
41. Hammond, S.M. 2006. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16:4-9.
42. Zhang, L., et al. 2006. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. U. S. A. 103:9136-9141.
43. Gaur, A., et al. 2007. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67:2456-2468.
44. Iorio, M.V., et al. 2005. microRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065-7070.
45. Fraga, M.F., and Esteller, M. 2005. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle. 4:144-148.
46. Saito, Y., et al. 2006. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 9:435-443.
47. Lujambio, A., et al. 2007. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67:1424-1429.
48. Kim, V.N., and Nam, J.W. 2006. Genomics of microRNA. Trends Genet. 22:165-173.
49. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R., and Jacks, T. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39:673-677.
50. Karube, Y., et al. 2005. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96:111-115.
51. Harris, K.S., Zhang, Z., McManus, M.T., Harfe, B.D., and Sun, X. 2005. Dicer function is essential for lung epithelium morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 103:2208-2213.
52. Chiosea, S., et al. 2007. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67:2345-2350.
53. Gauwerky, C.E., Huebner, K., Isobe, M., Nowell, P.C., and Croce, C.M. 1989. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 86:8867-8871.
54. Barlund, M., et al. 2000. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res. 60:5340-5344.
55. Sanchez-Beato, M., Sanchez-Aguilera, A., and Piris, M.A. 2003. Cell cycle deregulation in B-cell lymphomas. Blood. 101:1220-1235.
56. Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C., and Croce, C.M. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1097-1099.
57. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C.M. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228:1440-1443.
58. Chiorazzi, N., Rai, K.R., and Ferrarini, M. 2005. Chronic lymphocytic leukemia. N. Engl. J. Med. 352:804-815.
59. Kitada, S., et al. 1998. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood. 91:3379-3389.
60. Adachi, M., Tefferi, A., Greipp, P.R., Kipps, T.J., and Tsujimoto, Y. 1990. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J. Exp. Med. 171:559-564.
61. Cimmino, A., et al. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 102:13944-13949.
62. Mayr, C., Hemann, M.T., and Bartel, D.P. 2007. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 315:1576-1579.
63. Lee, Y.S., and Dutta, A. 2007. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21:1025-1030.
64. Sonoki, T., Iwana, E., Mitsuya, H., and Asou, N. 2005. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia. 19:2009-2010.
65. Schwindt, H., et al. 2006. Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination. J. Neuropathol. Exp. Neurol. 65:776-782.
66. Bullrich, F., et al. 2001. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res. 61:6640-6648.
67. Migliazza, A., et al. 2001. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood. 97:2098-2104.
68. Calin, G.A., et al. 2005. A unique microRNA signature associated with prognostic factors and disease progression in B cell chronic lymphocytic leukemia. N. Engl. J. Med. 353:1793-1801.
69. Raveche, E.S., et al. 2007. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood. 109:5079-5086.
70. Volinia, S., et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103:2257-2261.
71. Linsley, P.S., et al. 2007. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 27:2240-2252.
72. Ciafre, S.A., et al. 2005. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334:1351- 1358.
73. Krichevsky, A.M., King, K.S., Donahue, C.P., Khrapko, K., and Kosik, K.S. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 9:1274-1281.
74. Wang, T., et al. 2007. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 46:336-347.
75. Chan, J.A., Krichevsky, A.M., and Kosik, K.S. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65:6029-6033.
76. Meng, F., et al. 2006. Involvement of human microRNAs in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 130:2113-2129.
77. Si, M.L., et al. 2006. miR-21-mediated tumor growth. Oncogene. 26:2799-2803.
78. Zhu, S., Si, M.L., Wu, H., and Mo, Y.Y. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282:14328-14336.
79. Costinean, S. 2006. Pre B cell proliferation and lymphoblastic leukemia/high grade lymphoma in Emiu miR 155 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 103:7024-7029.
80. Metzler, M., Wilda, M., Busch, K., Viehmann, S., and Borkhardt, A. 2004. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer. 39:167-169.
81. Eis, P.S., et al. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102:3627-3632.
82. Kluiver, J., et al. 2005. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207:243-249.
83. Rodriguez, A., et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science. 316:608-611.
84. Thai, T.H., et al. 2007. Regulation of the germinal center response by microRNA-155. Science. 316:604-608.
85. Sevignani, C., et al. 2007. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc. Natl. Acad. Sci. U. S. A. 104:8017-8022.
86. Dohner, H., et al. 2000. Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. 343:1910-1916.
87. Pekarsky, Y., et al. 2006. Tcl1 expression in CLL is regulated by miR-29 and miR-181. Cancer Res. 66:11590-11593.
88. Lu, J., et al. 2005. MicroRNA expression profiles classify human cancers. Nature. 435:834-838.
89. Murakami, Y., et al. 2006. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 25:2537-2545.
90. He, H., et al. 2005. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U. S. A. 102:19075-19080.
91. Weber, F., Teresi, R.E., Broelsch, C.E., Frilling, A., and Eng, C. 2006. A limited set of human Micro-RNA is deregulated in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 91:3584-3591.
92. Takamizawa, J., et al. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64:3753-3756.
93. Yanaihara, N., et al. 2006. microRNA signature in lung cancer diagnosis and prognosis. Cancer Cell. 9:189-198.
94. Michael, M.Z., O' Connor, S.M., van Holst Pellekaan, N.G., Young, G.P., and James, R.J. 2003. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1:882-891.
95. Cummins, J.H., et al. 2006. The colorectal micro-RNAome. Proc. Natl. Acad. Sci. U. S. A. 103:3687-3692.
96. Bottoni, A., et al. 2007. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J. Cell. Physiol. 210:370-377.
97. Weiler, J., Hunziker, J., and Hall, J. 2005. AntimiRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther. 13:496-502.
98. Orom, U.A., Kauppinen, S., and Lund, A.H. 2006. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene. 372:137-141.
99. Naguibneva, I., et al. 2006. An LNA-based loss-of-function assay for micro-RNAs. Biomed. Pharmacother. 60:633-638.
100. Krutzfeldt, J., et al. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 438:685-689.
101. Krutzfeldt, J., et al. 2007. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35:2885-2892.